USV announces investment in Humane Genomics, which uses AI-designed synthetic oncolytic viruses to reprogram cancer cells, starting with pediatric liver cancer.
Topics: Biotech & Life Sciences · Healthcare
Published by USV · their site ↗
SandHill indexes 800+ venture capital blogs and newsletters and sends the best of them every Sunday. Browse the sources · browse by topic · read the blog.
Suggest a blog or newsletter for the SandHill index. We track the RSS feed and feature the best pieces in the weekly digest.
The latest theses & analyses from 800+ venture investors, curated into one email. Join 5,000+ investors, founders and LPs.